TITLE

Improved Postprandial Glycemic Control With Insulin Aspart

AUTHOR(S)
Lindholm, Anders; McEwen, John; Riis, Anders P.
PUB. DATE
May 1999
SOURCE
Diabetes Care;May99, Vol. 22 Issue 5, p801
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information on a study which compared the postprandial serum glucose control after administration of insulin aspart, a rapid-acting insulin analog, with that of unmodified human insulin in patients with type one diabetes. Research design and methods; Results; Conclusions.
ACCESSION #
2025253

 

Related Articles

  • Obesity, Inflammation, and Insulin Resistance – A Mini-Review. Zeyda, Maximilian; Stulnig, Thomas M. // Gerontology;Jul2009, Vol. 55 Issue 4, p379 

    The association of obesity, insulin resistance, and chronic low-grade inflammation has been evident for several years by now. Since obesity, insulin resistance, and inflammation all are related to aging as well, the mechanisms underlying this association are of critical importance for...

  • Evaluation of the Effects of Nateglinide on Postprandial Glycemia in Patients with Type 2 Diabetes mellitus: A Multicenter, Multinational, Non-Randomized, Non-Controlled Latin American Study. Islas-Andrade, Sergio; Revilla-Monsalve, Maria Cristina; Caminos, Quenemari R.; Chacín, Luis F.; Yupanqui, Hernán; López, Gloria; de la Torre, Walter; de Hurtado, Evelyn Martínez // Pharmacology;Jun2003, Vol. 68 Issue 2, p89 

    One hundred and sixteen Latin American type two diabetic patients previously only on a diet were enrolled in this multicenter, multinational, nonrandomized, noncontrolled study. Only 109 completed the study. After eight weeks of treatment with 120 mg of nateglinide, administered prior to each...

  • Insulin. Jordan, Sue; Lake, Richard // Nursing Standard;4/20/2005, Vol. 19 Issue 32, Following p96 

    Discusses information about insulin, which is prescribed to compensate for the failure of the pancreas that occurs in diabetes mellitus. Administration; Drug interactions; Cautions; Hypoglycemia.

  • Premixing and preloading insulin. Thomas, Sue // Primary Health Care;Sep2005, Vol. 15 Issue 7, p24 

    Examines the issues regarding the Royal College of Nursing guidance on premixing and preloading of insulin at home. Responses from community nurses in Great Britain; Possible risks of microbial contamination and unknown chemical stability; Solutions for practical issues.

  • Insulin Glargine (rDNA origin) Injection.  // AHFS Consumer Medication Information;Jul2020, p1 

    Insulin glargine is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore,...

  • Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase. MORROW, LINDA; MUCHMORE, DOUGLAS B.; HOMPESCH, MARCUS; LUDINGTON, ELIZABETH A.; VAUGHN, DANIEL E. // Diabetes Care;Feb2013, Vol. 36 Issue 2, p273 

    OBJECTIVE--To compare the pharmacokinetics and glucodynamics of three rapid-acting insulin analogs (aspart, glulisine, and lispro) injected subcutaneously with or without recombinant human hyaluronidase (rHuPH20). RESEARCH DESIGN ANDMETHODS--This double-blind six-way crossover euglycemic glucose...

  • Repeated Hypoglycemia Caused by the Overproduction of Anti-insulin Antibodies and Isolated ACTH Deficiency in a Type2 Diabetic Patient Receiving Insulin Therapy. YOSHIDA, MASANORI; MURAKAMI, MIHO; OGAWA, KOICHIRO; ASAI, MASATO; MIYATA, MISAKI; MAEDA, HARUMI; OISO, YUTAKA // Diabetes Care;Feb2013, Vol. 36 Issue 2, pe22 

    The article reports on a case of repeated hypoglycemia caused by overproduction of anti-insulin antibodies in a 46-year-old man with untreated type 2 diabetes. One year after his insulin therapy, the patient experienced frequent hypoglycemic attacks which persisted despite reducing his insulin...

  • Troglitazone for insulin-resistant diabetes.  // American Family Physician;4/1/1997, Vol. 55 Issue 5, p1985 

    Presents information about the approval of the Food and Drug Administration on troglitazone (Rezulin) as the first anti-diabetes drug that targets the underlying cause of type II diabetes mellitus. Required dosage of troglitazone for patients receiving insulin injection; Most common adverse...

  • Inhaled insulin effective long-term.  // Pulse;6/7/2004, Vol. 64 Issue 23, p9 

    Reports on research from the U.S. on the efficacy of inhaled insulin on glycaemic control and pulmonary function in patients with diabetes.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics